The mitochondrial calcium uniporter (MCU) activates mitochondrial respiration and enhances mobility by regulating mitochondrial redox state.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
08 2023
Historique:
received: 21 04 2023
revised: 14 05 2023
accepted: 21 05 2023
medline: 12 7 2023
pubmed: 12 6 2023
entrez: 11 6 2023
Statut: ppublish

Résumé

Regulation of mitochondrial redox balance is emerging as a key event for cell signaling in both physiological and pathological conditions. However, the link between the mitochondrial redox state and the modulation of these conditions remains poorly defined. Here, we discovered that activation of the evolutionary conserved mitochondrial calcium uniporter (MCU) modulates mitochondrial redox state. By using mitochondria-targeted redox and calcium sensors and genetic MCU-ablated models, we provide evidence of the causality between MCU activation and net reduction of mitochondrial (but not cytosolic) redox state. Redox modulation of redox-sensitive groups via MCU stimulation is required for maintaining respiratory capacity in primary human myotubes and C. elegans, and boosts mobility in worms. The same benefits are obtained bypassing MCU via direct pharmacological reduction of mitochondrial proteins. Collectively, our results demonstrate that MCU regulates mitochondria redox balance and that this process is required to promote the MCU-dependent effects on mitochondrial respiration and mobility.

Identifiants

pubmed: 37302345
pii: S2213-2317(23)00160-X
doi: 10.1016/j.redox.2023.102759
pmc: PMC10363449
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP
mitochondrial calcium uniporter 0
Mcu-1 protein, C elegans 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102759

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.W., A.H., F.B. , F.S., S.K., V.S., J.N.F and J. U.D.M. are or were employees of Nestlé Research, which is part of the Société des Produits Nestlé SA.

Références

J Muscle Res Cell Motil. 2021 Jun;42(2):281-289
pubmed: 32034582
Dev Cell. 2014 Oct 13;31(1):48-60
pubmed: 25313960
Cell Rep. 2021 Jun 22;35(12):109275
pubmed: 34161774
EMBO J. 1999 Jan 4;18(1):96-108
pubmed: 9878054
Mol Cell. 2010 Apr 23;38(2):280-90
pubmed: 20417605
Mol Cell. 2017 Mar 16;65(6):1014-1028.e7
pubmed: 28262504
Nat Genet. 2014 Feb;46(2):188-93
pubmed: 24336167
Neurol Genet. 2016 Mar 03;2(2):e59
pubmed: 27123478
Nat Protoc. 2013 Nov;8(11):2105-18
pubmed: 24113784
Life (Basel). 2022 Jan 29;12(2):
pubmed: 35207491
Curr Protoc Neurosci. 2016 Oct 3;77:8.37.1-8.37.21
pubmed: 27696358
Biochemistry. 2006 Feb 28;45(8):2524-36
pubmed: 16489745
Cells. 2020 Feb 12;9(2):
pubmed: 32059571
Biochem J. 2008 Sep 15;414(3):441-52
pubmed: 18518861
Cell Rep. 2015 Mar 3;10(8):1269-79
pubmed: 25732818
Front Physiol. 2020 Oct 07;11:554904
pubmed: 33117189
Neurobiol Dis. 2020 Jun;139:104786
pubmed: 32032734
Cell Calcium. 2018 Sep;74:86-93
pubmed: 29980025
Cell Rep. 2019 Oct 29;29(5):1274-1286.e6
pubmed: 31665639
Biochim Biophys Acta Mol Cell Res. 2019 Jul;1866(7):1068-1078
pubmed: 30982525
Aging Dis. 2018 Aug 1;9(4):716-728
pubmed: 30090659
Nat Methods. 2017 Jun 29;14(7):671-672
pubmed: 28661497
FEBS J. 2010 Mar;277(6):1465-80
pubmed: 20148960
Nature. 2011 Jun 19;476(7360):336-40
pubmed: 21685888
Nutrients. 2020 Feb 19;12(2):
pubmed: 32093050
Int J Mol Sci. 2020 Nov 16;21(22):
pubmed: 33207633
Biol Chem. 2015 May;396(5):465-82
pubmed: 25720067
Biochem J. 2004 Nov 15;384(Pt 1):19-24
pubmed: 15324303
J Cell Biol. 2020 Jun 1;219(6):
pubmed: 32259199
Biochemistry. 2012 Apr 10;51(14):2959-73
pubmed: 22443365
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4909-14
pubmed: 12657731
BMC Physiol. 2008 Apr 02;8:7
pubmed: 18384668
Nat Med. 2014 Jul;20(7):709-11
pubmed: 24999941
Nature. 2017 Dec 14;552(7684):187-193
pubmed: 29211722
Redox Biol. 2020 Sep;36:101606
pubmed: 32604037
FASEB J. 2015 Dec;29(12):4766-71
pubmed: 26253366
Antioxidants (Basel). 2018 Aug 08;7(8):
pubmed: 30096848
Cell Death Differ. 2019 Jan;26(2):362-381
pubmed: 30232375
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
Redox Biol. 2013 Dec 19;2:123-39
pubmed: 24455476
Nat Rev Mol Cell Biol. 2000 Oct;1(1):11-21
pubmed: 11413485
Biol Chem. 2015 May;396(5):401-13
pubmed: 25581754
Redox Biol. 2015 Aug;5:186-194
pubmed: 25974624
Chembiochem. 2020 Jul 16;21(14):1947-1954
pubmed: 32196882
Biomolecules. 2020 Jan 06;10(1):
pubmed: 31935965
Nat Rev Mol Cell Biol. 2012 Sep;13(9):566-78
pubmed: 22850819
Front Physiol. 2020 Dec 23;11:617492
pubmed: 33424641
Biochem J. 2009 Jan 1;417(1):1-13
pubmed: 19061483
Nat Protoc. 2016 Oct;11(10):1798-816
pubmed: 27583642
Cell Metab. 2014 May 6;19(5):757-66
pubmed: 24561260
Antioxid Redox Signal. 2021 May 10;34(14):1069-1082
pubmed: 33270507
Oncotarget. 2015 Nov 24;6(37):39469-81
pubmed: 26415224
Sci Transl Med. 2014 Jan 29;6(221):221ra15
pubmed: 24477002
Proc Natl Acad Sci U S A. 1989 Jan;86(2):471-5
pubmed: 2911592
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H459-76
pubmed: 23748424
Commun Biol. 2021 Aug 26;4(1):1013
pubmed: 34446827
Aging Cell. 2022 Jan;21(1):e13541
pubmed: 34953016
Nat Rev Mol Cell Biol. 2007 Oct;8(10):813-24
pubmed: 17848967
J Biol Chem. 2004 Mar 26;279(13):13044-53
pubmed: 14722062
Mol Cell. 2017 Aug 17;67(4):711-723.e7
pubmed: 28820965
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):422-7
pubmed: 19122143
Antioxid Redox Signal. 2012 Dec 15;17(12):1714-27
pubmed: 22530585
Int J Mol Sci. 2021 Mar 03;22(5):
pubmed: 33802289
Physiol Rep. 2016 Dec;4(24):
pubmed: 28039397
Front Oncol. 2020 Feb 28;10:256
pubmed: 32185131
Nature. 2011 Jun 19;476(7360):341-5
pubmed: 21685886
World J Biol Chem. 2015 Nov 26;6(4):310-23
pubmed: 26629314
PLoS One. 2008 May 21;3(5):e2208
pubmed: 18493300
Int J Mol Sci. 2021 Dec 22;23(1):
pubmed: 35008532
Mol Cell. 2019 Feb 21;73(4):775-787.e10
pubmed: 30642763
Biochemistry. 2013 Apr 23;52(16):2793-809
pubmed: 23547908

Auteurs

Anna Weiser (A)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland; Molecular Nutritional Medicine, Else Kröner Fresenius Center for Nutritional Medicine, Technische Universität München, 85354 Freising, Germany.

Aurélie Hermant (A)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland.

Flavien Bermont (F)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland.

Federico Sizzano (F)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland.

Sonia Karaz (S)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland.

Pilar Alvarez-Illera (P)

Department of Biochemistry and Molecular Biology, University of Valladolid, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), 47003 Valladolid, Spain.

Jaime Santo-Domingo (J)

Department of Biochemistry and Molecular Biology, University of Valladolid, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), 47003 Valladolid, Spain.

Vincenzo Sorrentino (V)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 119228, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 117596, Singapore.

Jerome N Feige (JN)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland.

Umberto De Marchi (U)

Nestlé Institute of Health Sciences, Nestlé Research, EPFL Innovation Park, CH-1015 Lausanne, Switzerland. Electronic address: umberto.demarchi@rd.nestle.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH